Results 11 to 20 of about 379,925 (396)
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer [PDF]
JAMA Oncology, 2021 Key Points Question Does apatinib prolong the progression-free survival of patients with progressive locally advanced or metastatic, radioactive iodine–refractory differentiated thyroid cancer compared with placebo?
Yansong Lin +24 more
semanticscholar +2 more sources
Radionuclide monitoring of targeted therapy of iodine-negative differentiated thyroid cancer
Український радіологічний та онкологічний журнал, 2021 Background. Current management of treating iodine-negative metastases of differentiated thyroid cancer has its features. In recent years, tyrosine kinase inhibitors (sorafenib, sunitinib) have been registered and indicated to treat refractory forms of ...
О. І. Солодянникова +3 more
doaj +1 more source
European Thyroid Journal, 2021 Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patients’ risk stratification.
F. Pacini +7 more
semanticscholar +1 more source
JAMA Surgery, 2021 Importance Owing to the good prognosis of differentiated thyroid cancer (DTC), guidelines recommend total thyroidectomy (TT) or thyroid lobectomy (TL) as surgical treatment for DTC with low to intermediate risk of recurrence.
Wanna Chen +14 more
semanticscholar +1 more source
Journal of Translational Medicine, 2023 Although the incidence of thyroid cancer is increasing year by year, most patients, especially those with differentiated thyroid cancer, can usually be cured with surgery, radioactive iodine, and thyroid-stimulating hormone suppression.
Sai-li Duan +3 more
doaj +1 more source
Investigating the association of rs2910164 with cancer predisposition in an Irish cohort. [PDF]
, 2017 IntroductionMicroRNAs (miRNAs) are small noncoding RNA molecules that exert post-transcriptional effects on gene expression by binding with cis-regulatory regions in target messenger RNA (mRNA).
Bell, M +11 more
core +6 more sources
Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus. [PDF]
PLoS ONE, 2013 BACKGROUND: Increased body mass index is related to the incidence of thyroid cancer. However, the presentation and therapeutic outcomes of different thyroid cancers and type 2 diabetes mellitus (DM) have not been studied.
Szu-Tah Chen +3 more
doaj +1 more source
Korean Journal of Radiology, 2021 Imaging plays a key role in the diagnosis and characterization of thyroid diseases, and the information provided by imaging studies is essential for management planning.
Ji Ye Lee +15 more
semanticscholar +1 more source
Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer [PDF]
Endocrinology and Metabolism, 2017 The incidence of thyroid cancer is growing the fastest among all cancers in the United States, especially in women. The number of patients with thyroid neoplasm is part of an even larger number of patients who often need to undergo an operation to ...
Xuguang Zhu, Sheue-yann Cheng
doaj +1 more source
Management of Differentiated Thyroid Cancer: The Standard of Care
Journal of Nuclear Medicine, 2021 In the past decade, the management of differentiated thyroid cancer (DTC) underwent a paradigm shift toward the use of risk stratification with the goal of maximizing the benefit and minimizing the morbidity of radioiodine (131I) therapy. 131I therapy is
A. Avram +3 more
semanticscholar +1 more source